IL4I1 and central nervous system cancer: We performed PCR in clinical samples including six normal brain tissues, 22 low grade gliomas (LGG), and 51 GBMs and found that the expression level of IL4I1 in GBM was significantly higher compared with that in normal brain tissues and LGG (Figure 1E).